Antiretroviral therapy (ART) has proven lifesaving for people infected with HIV; however, the medications are a lifelong necessity for most HIV-infected individuals and present practical, logistical, economic and health-related challenges. A primary research goal is to find an HIV cure that either clears the virus from an infected person's body or enables HIV-infected individuals to suppress virus levels and replication to extremely low levels without the need for daily ART.
In a new perspective article, National Institute of Allergy and Infectious Diseases (NIAID) director Anthony S. Fauci, MD, and colleagues describe how persistent HIV reservoirs form in the human body and why they pose formidable challenges to achieving a cure. Additionally, the authors discuss the current therapeutic research strategies aimed at eliminating or controlling the virus without daily ART, including making CD4+ T cells resistant to HIV and enhancing host immunity against infection. A better understanding of persistent viral reservoirs and the impact of therapeutic interventions on these reservoirs is essential to the development of successful therapeutic strategies aimed at the long-term control of HIV infection, according to the authors.
While recent scientific advances and increased funding aimed at developing therapeutic strategies toward an HIV cure have yielded valuable insights into the pathogenesis of HIV-related disease, achieving an HIV cure remains extremely challenging, the authors note. However, recent advances give cause for hope. Attaining a cure will require strong and sustained efforts to better understand the establishment, composition, maintenance, and renewal of HIV reservoirs, according to the authors.
Reference: Chun TW, et al. HIV Reservoirs: Obstacles and Opportunities for an HIV Cure. Nature Immunology DOI: 10.1038/ni.3152 (2015).
Source: NIH/National Institute of Allergy and Infectious Diseases
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.